Evidence map›Paper›PMID 19876412›Full record

ReviewTexas Heart Institute journal2009

The comparative efficacy of percutaneous and surgical coronary revascularization in 2009: a review.

Stephen A May, James M Wilson

Abstract readHistorical ArticleReview
In one paragraph

Review in Texas Heart Institute journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stephen A MayDepartment of Cardiology, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas 77030, USA.
James M Wilson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical, percutaneous, and surgical therapies for coronary atherosclerotic disease are developing rapidly, with many recent breakthroughs in metabolic control, improvements in catheter and stent engineering, and advances in surgical technique. Treatment guidelines are still in their infancy and do not take into account several of these recent innovations. Consequently, determining the most appropriate treatment for many patients remains challenging. In this review, we examine the most recent revascularization guidelines, discuss important new data and trials comparing contemporary stent technology and coronary artery bypass surgery, and conclude with updated revascularization recommendations.

Indexed as

Angioplasty, Balloon, CoronaryCoronary Artery BypassComorbidityCoronary Artery DiseaseDrug-Eluting StentsEvidence-Based MedicineHistory, 20th CenturyHistory, 21st CenturyHumansPatient SelectionPractice Guidelines as TopicRisk AssessmentRisk FactorsStentsTreatment OutcomeCoronary artery bypass/methods/mortalitycoronary artery disease/therapycoronary stenosis/therapydrug-eluting stentsmyocardial revascularization/methods/trendspercutaneous coronary interventionretreatment

Identifiers

PMID19876412
PMCPMC2763449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.